Annual Total Long Term Liabilities
$97.09 M
-$18.13 M-15.73%
December 31, 2023
Summary
- As of February 27, 2025, RXRX annual total long term liabilities is $97.09 million, with the most recent change of -$18.13 million (-15.73%) on December 31, 2023.
- During the last 3 years, RXRX annual total long term liabilities has fallen by -$384.68 million (-79.85%).
- RXRX annual total long term liabilities is now -79.85% below its all-time high of $481.77 million, reached on December 31, 2020.
Performance
RXRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$93.05 M
-$12.28 M-11.66%
September 30, 2024
Summary
- As of February 27, 2025, RXRX quarterly total long term liabilities is $93.05 million, with the most recent change of -$12.28 million (-11.66%) on September 30, 2024.
- Over the past year, RXRX quarterly long term liabilities has stayed the same.
- RXRX quarterly long term liabilities is now -80.69% below its all-time high of $481.77 million, reached on December 1, 2020.
Performance
RXRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
RXRX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.7% | 0.0% |
| 3 y3 years | -79.8% | -19.2% |
| 5 y5 years | -55.7% | -19.2% |
RXRX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.7% | +367.9% | -40.0% | +348.5% |
| 5 y | 5-year | -79.8% | +367.9% | -80.7% | +459.5% |
| alltime | all time | -79.8% | +367.9% | -80.7% | +459.5% |
Recursion Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $93.05 M(-11.7%) |
| Jun 2024 | - | $105.33 M(+27.2%) |
| Mar 2024 | - | $82.78 M(-14.7%) |
| Dec 2023 | $97.09 M(-15.7%) | $97.09 M(-1.7%) |
| Sep 2023 | - | $98.74 M(+17.9%) |
| Jun 2023 | - | $83.78 M(-20.2%) |
| Mar 2023 | - | $105.04 M(-8.8%) |
| Dec 2022 | $115.22 M | $115.22 M(-18.0%) |
| Sep 2022 | - | $140.46 M(+1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $138.28 M(-10.8%) |
| Mar 2022 | - | $155.05 M(+647.3%) |
| Dec 2021 | $20.75 M(-95.7%) | $20.75 M(+24.8%) |
| Sep 2021 | - | $16.63 M(-36.9%) |
| Jun 2021 | - | $26.34 M(-94.5%) |
| Mar 2021 | - | $478.12 M(-0.8%) |
| Dec 2020 | $481.77 M(+120.0%) | - |
| Dec 2020 | - | $481.77 M |
| Dec 2019 | $219.01 M | - |
FAQ
- What is Recursion Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Recursion Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Recursion Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of RXRX is $97.09 M
What is the all time high annual total long term liabilities for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual total long term liabilities is $481.77 M
What is Recursion Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, RXRX annual total long term liabilities has changed by -$18.13 M (-15.73%)
What is Recursion Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of RXRX is $93.05 M
What is the all time high quarterly long term liabilities for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly total long term liabilities is $481.77 M
What is Recursion Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, RXRX quarterly total long term liabilities has changed by $0.00 (0.00%)